Azenta, Inc. (AZTA) Tops Q4 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Azenta, Inc. (AZTA) PT Lowered to $48 at Evercore ISI
November 13, 2024 5:43 AM ESTEvercore ISI analyst Vijay Kumar lowered the price target on Azenta, Inc. (NASDAQ: AZTA) to $48.00 (from $50.00) while maintaining a In Line rating.
The analyst comments 4Q Results: AZTAs org revs declined -2%, with total revs of $170 MM inline with ST. SMS... More
Azenta, Inc. (AZTA) to Sell B Medical Systems, Appoints Lawrence Y. Lin as CFO
November 12, 2024 4:06 PM ESTAzenta, Inc. (Nasdaq: AZTA) today reported financial results for the fourth quarter and fiscal year ended September 30, 2024.
Fiscal Year 2024 Highlights:
Q4'24 revenue growth of 6% reported and 5% organic, in combined Sample Management Solutions and MultiomicsFY'24 Adjusted EBITDA margin expansion of approximately 300 basis points versus last year
Quarter Ended
... More